Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

Drug Enforcement Administration

TitleSourceLinkYear
t-boc norfentanylUS Drug Enforcement Administration; SWGDRUG; 2023swgdrug.org/Monographs/t-boc%20Norfentanyl.pdf2023
Examination of Latent Print EvidenceDrug Enforcement Administration; 119pp; 2023www.dea.gov/documents/2023/2023-11/2023-11-20/lom-7700-examination-latent-print-evidence2023
MDMB-4en-PINACAUS Drug Enforcement Administration; SWGDRUG; 2023swgdrug.org/Monographs/MDMB-4en-PINACA.pdf2023
Standard Operating Procedure for the Analysis of Suspected MethamphetamineDrug Enforcement Administration; 2023www.dea.gov/documents/2023/2023-11/2023-11-20/standard-operating-procedure-analysis-suspected-methamphetamine2023
Examination of Friction Ridge EvidenceDrug Enforcement Administration; 2023www.dea.gov/documents/2023/2023-11/2023-11-20/lom-7700-examination-friction-ridge-evidence2023
6-MAPBUS Drug Enforcement Administration; SWGDRUG; 2023swgdrug.org/Monographs/6-MAPB.pdf2023
3-Chloro-N,N-dimethylcathinoneUS Drug Enforcement Administration; SWGDRUG; 2023swgdrug.org/Monographs/3-Chloro-N,N-Dimethylcathinone.pdf2023
Analysis of Drug EvidenceU.S. Drug Enforcement Administration; 221pp; November 2023www.dea.gov/documents/2023/2023-11/2023-11-13/lom-7500-analysis-drug-evidence2023
NFLIS-Drug Brief: Substances Co-Reported with Fentanyl in NFLIS-Drug and DEA-Tox, January 2013–June 2023U.S. Department of Justice, U.S. Drug Enforcement Administration; November 2023www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2023
DEA TOX: Quarterly Report – Second Quarter 2023U.S. Drug Enforcement Administration; 2023www.deadiversion.usdoj.gov/dea_tox/index.html2023
Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule IDrug Enforcement Administration; October 25, 2023www.federalregister.gov/documents/2023/10/25/2023-23379/schedules-of-controlled-substances-temporary-placement-of-n-desethyl-isotonitazene-and-n-piperidinyl2023
Sourcing XylazineJoint Intrepid Laboratory; DEA; October 2023www.dea.gov/documents/2023/2023-10/2023-10-19/joint-intrepid-laboratory-releases-priority-project-sourcing2023
2022 Medical Examiner and Coroner Survey ReportDEA; DOJ; 12pp; October 2023www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2023
National Forensic Laboratory Information System: NFLIS-Drug 2022 annual reportDEA; September 2023www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2023
Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule IDEA; September 22, 2023www.federalregister.gov/documents/2023/09/22/2023-20439/schedules-of-controlled-substances-placement-of-ethylphenidate-in-schedule-i2023
Schedules of Controlled Substances: Placement of Metonitazene in Schedule IDEA; August 18, 2023www.federalregister.gov/documents/2023/08/18/2023-17778/schedules-of-controlled-substances-placement-of-metonitazene-in-schedule-i2023
Fentanyl Used in Vape PensDEA Bulletin; San Diego Field Division; September 2020www.dea.gov/documents/2020/2020-09/2020-09-14/fentanyl-used-vape-pens2020
Counterfeit Controlled Prescription Drug Availability in Pennsylvania & DelawareDEA Intelligence Report; September 2020www.dea.gov/documents/2020/2020-09/2020-09-21/counterfeit-controlled-prescription-drug-availability2020
Standard Operating Procedure for the Analysis of Suspected Cannabis Plant MaterialDEA Office of Forensic Sciences; 2023www.dea.gov/documents/2023/2023-08/2023-08-02/standard-operating-procedure-analysis-suspected-cannabis-plant2023
Standard Operating Procedure for the Analysis of Cannabis Liquids and ExtractsDEA Office of Forensic Sciences; 2023www.dea.gov/documents/2023/2023-08/2023-08-02/standard-operating-procedure-analysis-cannabis-liquids-and2023
Standard Operating Procedure for the Analysis of Suspected Natural and Synthetic OpioidsDEA Office of Forensic Sciences; 2023www.dea.gov/documents/2023/2023-08/2023-08-02/standard-operating-procedure-analysis-suspected-natural-and2023
Standard Operating Procedure for the Analysis of Suspected CocaineDEA Office of Forensic Sciences; 2023www.dea.gov/documents/2023/2023-08/2023-08-02/standard-operating-procedure-analysis-suspected-cocaine2023
DEA Tox – Quarterly Report – 1st Quarter 2023DEA; June 2023www.deadiversion.usdoj.gov/dea_tox/index.html2023
DEA TOX – 2022 Annual ReportDEA; 38pp; May 2023www.deadiversion.usdoj.gov/dea_tox/index.html2023
Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in ScheduleDEA; April 13, 2023www.federalregister.gov/documents/2023/04/13/2023-07576/schedules-of-controlled-substances-placement-of-nine-specific-fentanyl-related-substances-in2023
Designation of Halides of 4-Anilinopiperidine as List I ChemicalsDEA; April 14, 2023www.federalregister.gov/documents/2023/04/14/2023-07454/designation-of-halides-of-4-anilinopiperidine-as-list-i-chemicals2023
Announcement of an Emerging Compound – MedetomidineDEA Synth-Opioids Real-time Communication Network; NFLIS; March 2023 (retrieved from https://synthopioids.nflis.deadiversion.usdoj.gov/ with permission from Agnes Winokur)forensiclibrary.org/archives/318772023
Schedules of Controlled Substances: Placement of Brorphine in Schedule IDEA; March 6, 2023www.federalregister.gov/documents/2023/03/06/2023-04364/schedules-of-controlled-substances-placement-of-brorphine-in-schedule-i2023
DEA Tox – Quarterly Report – 4th QuarterDEA; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule IDEA; December 23, 2022www.federalregister.gov/documents/2022/12/23/2022-27278/schedules-of-controlled-substances-temporary-placement-of-etizolam-flualprazolam-clonazolam2022
Summary of Validated Quantitative MethodsDEA; 40pp; December 2022www.dea.gov/documents/2022/2022-12/2022-12-07/summary-validated-quantitative-methods2022
Summary of Validated Qualitative MethodsDEA; 106pp; December 2022www.dea.gov/documents/2022/2022-12/2022-12-07/summary-validated-qualitative-methods2022
Drugs of Abuse – A DEA Resource Guide – 2022 EditionDEA; 115pp; 2022www.dea.gov/documents/2022/2022-12/2022-12-02/drugs-abuse-20222022
DEA Tox – Toxicology Testing ProgramDEA; Third Quarter; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Placement of Mesocarb in Schedule IDEA; November 22, 2022www.federalregister.gov/documents/2022/11/22/2022-25219/schedules-of-controlled-substances-placement-of-mesocarb-in-schedule-i2022
Schedules of Controlled Substances: Placement of Zipeprol in Schedule IDEA; November 21, 2022www.federalregister.gov/documents/2022/11/21/2022-25206/schedules-of-controlled-substances-placement-of-zipeprol-in-schedule-i2022
Schedules of Controlled Substances: Placement of Amineptine in Schedule IDEA; November 17, 2022www.federalregister.gov/documents/2022/11/17/2022-25003/schedules-of-controlled-substances-placement-of-amineptine-in-schedule-i2022
Schedules of Controlled Substances: Placement of Daridorexant in Schedule IVDEA; September 30, 2022www.federalregister.gov/documents/2022/09/30/2022-21253/schedules-of-controlled-substances-placement-of-daridorexant-in-schedule-iv2022
NFLIS-Drug SnapshotDEA; June 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2021
DEA Tox – Quarterly Report – 2nd QuarterDEA; August 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IVDEA; June 24, 2022www.federalregister.gov/documents/2022/06/24/2022-13538/schedules-of-controlled-substances-placement-of-serdexmethylphenidate-in-schedule-iv2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I\DrugDEA; June 6, 2022www.federalregister.gov/documents/2022/06/06/2022-11933/schedules-of-controlled-substances-placement-of-methoxetamine-mxe-in-schedule-i2022
Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule IDEA; June 1, 2022www.federalregister.gov/documents/2022/06/01/2022-11740/schedules-of-controlled-substances-placement-of-n-ethylhexedrone-alpha-pyrrolidinohexanophenone2022
Schedules of Controlled Substances: Placement of Ganaxolone in Schedule VDEA; June 1www.federalregister.gov/documents/2022/06/01/2022-11735/schedules-of-controlled-substances-placement-of-ganaxolone-in-schedule-v2022
DEA TOX: Quarterly Report – 1st Quarter 2022DEA; May 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
NFLIS-Drug 2021 midyear reportDEA; 32pp; April 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Synth-Opioids Real-Time Communication Network – 2021 annual reportNFLIS; April 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule IDEA; April 11, 2022www.federalregister.gov/documents/2022/04/11/2022-07648/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-iodoamphetamine-doi-and2022
Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I; Final ruleDEA; April 7, 2022www.federalregister.gov/documents/2022/04/07/2022-07320/schedules-of-controlled-substances-placement-of-5f-edmb-pinaca-5f-mdmb-pica-fub-akb482022
DEA TOX: Quarterly Report – 4th Quarter 2021DEA; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
NFLIS-Drug Special Report: Gabapentin and Pregabalin Reported in NFLIS, 2011–2020DEA; 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Emoji Drug Code DecodedDrug Enforcement Administration; January 2022www.dea.gov/sites/default/files/2021-12/Emoji%20Decoded.pdf2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule IDrug Enforcement Administration; December 7, 2021www.federalregister.gov/documents/2021/12/07/2021-26293/schedules-of-controlled-substances-placement-of-methoxetamine-mxe-in-schedule-i2021
Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule IDrug Enforcement Administration; December 7, 2021www.federalregister.gov/documents/2021/12/07/2021-26263/schedules-of-controlled-substances-temporary-placement-of-butonitazene-etodesnitazene-flunitazene2021
Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I ChemicalDocument Number 2021-24952, 86 FR 64362, pp 64362-64366, November 18, 2021www.federalregister.gov/documents/2021/11/18/2021-24952/designation-of-methyl-alpha-phenylacetoacetate-a-precursor-chemical-used-in-the-illicit-manufacture2021
NFLIS-Drug 2020 Annual ReportNFLIS; 36pp; 2021www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2021
Emerging Threat Report; Mid-Year 2021Drug Enforcement Administration; October 2021forensiclibrary.org/archives/6835#2021
Schedules of Controlled Substances: Placement of Isotonitazene in Schedule IDEA; November 4www.federalregister.gov/documents/2021/11/04/2021-23848/schedules-of-controlled-substances-placement-of-isotonitazene-in-schedule-i2021
Schedules of Controlled Substances: Placement of Methiopropamine in Schedule IDepartment of Justice; September 2, 2021downloads.regulations.gov/DEA_FRDOC_0001-0381/content.pdf2021
Laboratory Operations ManualDEA; 269 pages; 2021www.dea.gov/documents/2019/2019-11/2019-11-15/laboratory-operations-manual2021
Schedules of Controlled Substances: Placement of Mesocarb in Schedule IDrug Enforcement Administration; Department of Justice; August 11, 2021www.govinfo.gov/content/pkg/FR-2021-08-11/pdf/2021-16489.pdf2021
Global Forensic and Justice Center

11200 SW 8th Street
Miami, FL 33199
Contact Us